Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
27 /100
MEDIUM RISK
Score updated Aug 28, 2026

CGON — CG Oncology, Inc. Dilution Risk Tracker

Track CGON dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CGON — Get alerts when the score changes →

As of August 28, 2026, CG Oncology, Inc. (CGON) has a DilutionWatch DilutionScore of 27/100, rated MEDIUM dilution risk. CG Oncology, Inc. has a market capitalization of $5.49B, 88.64M shares outstanding, 239 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for CGON.
🔔 Track CGON — Get forecast alerts →

Market Data

Market Cap$5.49B
Shares Outstanding88.64M
Float65.82M
Cash$1.03B
Debt$3.00M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 19.5% shares (2026Q1 vs prior)
239 institutional holders · 103.33M shares
#1 RTW INVESTMENTS, LP 6.98M shares
#2 T. Rowe Price Investment Management, Inc. 6.72M shares
#3 Decheng Capital LLC 6.37M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest11.84M
Days to Cover13.5
% of Float18.0%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2024-12-31
4 INSIDER TRANSACTION 2026-04-16
4 INSIDER TRANSACTION 2026-04-16
4 INSIDER TRANSACTION 2026-04-16
4 INSIDER TRANSACTION 2026-04-16
Full SEC filing analysis available with free account

Recent News

No recent news

Factual CGON Dilution Snapshot

CG Oncology, Inc. (CGON) has a DilutionScore of 27/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track CGON Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CGON — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CGON
CGON FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.